| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 代理产品(元) | 34,371,172.63 | 108,511,779.86 | 41,891,053.48 | 113,817,053.59 | 57,502,444.42 |
| 活性原料(元) | 8,037,268.70 | 14,713,367.36 | 6,402,497.28 | 22,756,753.08 | 13,330,287.05 |
| 疫苗(元) | 428,414,881.99 | 457,052,000.90 | 171,733,366.31 | 606,432,558.89 | 525,603,747.32 |
| 诊断试剂(元) | 519,403,947.39 | - | 565,687,526.74 | - | 724,141,690.64 |
| 诊断仪器(元) | 38,281,715.23 | - | 41,969,465.54 | - | 31,925,635.27 |
| 试剂(元) | - | 1,124,825,624.48 | - | 1,433,300,032.38 | - |
| 仪器(元) | - | 60,515,118.06 | - | 38,784,375.51 | - |
| 营业成本(元) | |||||
| 代理产品(元) | 15,799,563.53 | 69,856,936.40 | 20,733,757.98 | 50,273,673.43 | 31,260,858.10 |
| 活性原料(元) | 1,916,662.77 | 1,021,314.01 | 2,322,237.75 | 2,232,504.44 | 1,022,478.71 |
| 疫苗(元) | 127,492,035.15 | 332,486,939.87 | 70,278,177.70 | 179,306,715.39 | 157,586,097.82 |
| 诊断试剂(元) | 121,308,290.92 | - | 163,307,027.09 | - | 136,585,945.36 |
| 诊断仪器(元) | 103,324,242.19 | - | 70,285,033.02 | - | 33,724,806.85 |
| 试剂(元) | - | 331,739,005.20 | - | 351,758,714.62 | - |
| 仪器(元) | - | 160,250,016.80 | - | 159,233,721.51 | - |
| 毛利(元) | |||||
| 代理产品(元) | 18,571,609.10 | 38,654,843.46 | 21,157,295.50 | 63,543,380.16 | 26,241,586.32 |
| 活性原料(元) | 6,120,605.93 | 13,692,053.35 | 4,080,259.53 | 20,524,248.64 | 12,307,808.34 |
| 疫苗(元) | 300,922,846.84 | 124,565,061.03 | 101,455,188.61 | 427,125,843.50 | 368,017,649.50 |
| 诊断试剂(元) | 398,095,656.47 | - | 402,380,499.65 | - | 587,555,745.28 |
| 诊断仪器(元) | -65,042,526.96 | - | -28,315,567.48 | - | -1,799,171.58 |
| 试剂(元) | - | 793,086,619.28 | - | 1,081,541,317.76 | - |
| 仪器(元) | - | -99,734,898.74 | - | -120,449,346.00 | - |
| 毛利率(%) | |||||
| 代理产品(%) | 54.03 | 35.62 | 50.51 | 55.83 | 45.64 |
| 活性原料(%) | 76.15 | 93.06 | 63.73 | 90.19 | 92.33 |
| 疫苗(%) | 70.24 | 27.25 | 59.08 | 70.43 | 70.02 |
| 诊断试剂(%) | 76.64 | - | 71.13 | - | 81.14 |
| 诊断仪器(%) | -169.90 | - | -67.47 | - | -5.64 |
| 试剂(%) | - | 70.51 | - | 75.46 | - |
| 仪器(%) | - | -164.81 | - | -310.56 | - |
| 收入构成(%) | |||||
| 代理产品(%) | 3.34 | 6.15 | 5.06 | 5.14 | 4.25 |
| 活性原料(%) | 0.78 | 0.83 | 0.77 | 1.03 | 0.99 |
| 疫苗(%) | 41.65 | 25.89 | 20.75 | 27.38 | 38.86 |
| 诊断试剂(%) | 50.50 | - | 68.35 | - | 53.54 |
| 诊断仪器(%) | 3.72 | - | 5.07 | - | 2.36 |
| 试剂(%) | - | 63.71 | - | 64.71 | - |
| 仪器(%) | - | 3.43 | - | 1.75 | - |
| 毛利构成(%) | |||||
| 代理产品(%) | 2.82 | 4.44 | 4.23 | 4.32 | 2.64 |
| 活性原料(%) | 0.93 | 1.57 | 0.81 | 1.39 | 1.24 |
| 疫苗(%) | 45.69 | 14.31 | 20.26 | 29.01 | 37.09 |
| 诊断试剂(%) | 60.44 | - | 80.35 | - | 59.21 |
| 诊断仪器(%) | -9.87 | - | -5.65 | - | -0.18 |
| 试剂(%) | - | 91.13 | - | 73.46 | - |
| 仪器(%) | - | -11.46 | - | -8.18 | - |